Background: Although size is one of the strongest predictors, small aneurysms often rupture. We compared the characteristics of small and large ruptured intracranial aneurysms (RIAs) according to their location to find the factors associated with small RIAs in each location. Methods: Patients with subarachnoid hemorrhage due to saccular RIAs were consecutively enrolled. The sizes were dichotomized as small (<5 mm) or large, and the location was classified as paraclinoid-distal internal carotid artery, sidewalls of anterior or middle cerebral artery (MCA; sidewall), MCA-bifurcation, anterior or posterior communicating artery (Acom or Pcom, respectively), and posterior circulation RIAs. Independent factors associated with small RIAs compared to large RIAs were investigated in each location. Results: Small RIAs were observed in 384 of 791 patients (48.5%), and were most commonly located at Acom (17.1%) followed by Pcom (9.0%) and sidewalls (7.2%). Female sex (OR 3.038; 95% CI 2.099-4.395), young age (OR 0.971; 95% CI 0.958-0.985), hypertension (OR 1.412; 95% CI 1.033-1.930) and multiple aneurysms (OR 1.942; 95% CI 1.335-2.824) were associated with small RIAs. By location, sidewall aneurysms (OR 2.183; 95% CI 1.049-4.542) were associated with small RIAs, whereas MCA-bifurcation (OR 0.318; 95% CI 0.168-0.599) and Pcom aneurysms (OR 0.511; 95% CI 0.277-0.944) were associated with large RIAs. The presence of multiple aneurysms (OR 4.69; 95% CI 1.45-21.19) was associated with small RIAs at sidewalls, and young age, female sex, hypertension and the presence of bilateral A1 (OR 1.85; 95% CI 1.09-3.13) were associated with small RIAs at Acom. Acom RIAs with bilateral A1 was smaller than those with unilateral A1 (4.7 ± 2.1 vs. 5.8 ± 2.6 mm; p < 0.001). Conclusions: Intracranial aneurysms which rupture below 5 mm are not uncommon, and the factors associated with small-sized RIAs differ according to location. Sidewall aneurysms, with multiple aneurysms and Acom aneurysms with bilateral A1 may rupture even at small size.

Keywords:
Cerebral aneurysm, Risk factor, Subarachnoid hemorrhage
1.
Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G; European Stroke Organization: European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis 2013;35:93-112.
2.
Dolati P, Pittman D, Morrish WF, Wong J, Sutherland GR: The frequency of subarachnoid hemorrhage from very small cerebral aneurysms (< 5 mm): a population-based study. Cureus 2015;7:e279.
3.
Bijlenga P, Ebeling C, Jaegersberg M, Summers P, Rogers A, Waterworth A, Iavindrasana J, Macho J, Pereira VM, Bukovics P, Vivas E, Sturkenboom MC, Wright J, Friedrich CM, Frangi A, Byrne J, Schaller K, Rufenacht D; @neurIST Investigators: Risk of rupture of small anterior communicating artery aneurysms is similar to posterior circulation aneurysms. Stroke 2013;44:3018-3026.
4.
Zhao L, Zhang L, Zhang X, Li Z, Tian L, Wang YX: An analysis of 1256 cases of sporadic ruptured cerebral aneurysm in a single Chinese institution. PLoS One 2014;9:e85668.
5.
Tominari S, Morita A, Ishibashi T, Yamazaki T, Takao H, Murayama Y, Sonobe M, Yonekura M, Saito N, Shiokawa Y, Date I, Tominaga T, Nozaki K, Houkin K, Miyamoto S, Kirino T, Hashi K, Nakayama T; Unruptured Cerebral Aneurysm Study Japan Investigators: Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 2015;77:1050-1059.
6.
Lindner SH, Bor AS, Rinkel GJ: Differences in risk factors according to the site of intracranial aneurysms. J Neurol Neurosurg Psychiatry 2010;81:116-118.
7.
Alshekhlee A, Mehta S, Edgell RC, Vora N, Feen E, Mohammadi A, Kale SP, Cruz-Flores S: Hospital mortality and complications of electively clipped or coiled unruptured intracranial aneurysm. Stroke 2010;41:1471-1476.
8.
Sonobe M, Yamazaki T, Yonekura M, Kikuchi H: Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke 2010;41:1969-1977.
9.
Kaspera W, Ładziński P, Larysz P, Hebda A, Ptaszkiewicz K, Kopera M, Larysz D: Morphological, hemodynamic, and clinical independent risk factors for anterior communicating artery aneurysms. Stroke 2014;45:2906-2911.
10.
Xu L, Zhang F, Wang H, Yu Y: Contribution of the hemodynamics of A1 dysplasia or hypoplasia to anterior communicating artery aneurysms: a 3-dimensional numerical simulation study. J Comput Assist Tomogr 2012;36:421-426.
11.
Camuscu H, Dujovny M, Abd el-Bary T, Beristain X, Viñas FC: Microanatomy of the perforators of the anterior communicating artery complex. Neurol Res 1997;19:577-587.
12.
Kashiwazaki D, Kuroda S; Sapporo SAH Study Group: Size ratio can highly predict rupture risk in intracranial small (<5 mm) aneurysms. Stroke 2013;44:2169-2173.
13.
Castro MA, Putman CM, Sheridan MJ, Cebral JR: Hemodynamic patterns of anterior communicating artery aneurysms: a possible association with rupture. AJNR Am J Neuroradiol 2009;30:297-302.
14.
Hosoda K, Fujita S, Kawaguchi T, Shose Y, Hamano S: Saccular aneurysms of the proximal (M1) segment of the middle cerebral artery. Neurosurgery 1995;36:441-446.
15.
Campos C, Churojana A, Rodesch G, Alvarez H, Lasjaunias P: Multiple intracranial arterial aneurysms: a congenital metameric disease? Review of 113 consecutive patients with 280 AA. Interv Neuroradiol 1998;4:293-299.
16.
Cebral JR, Raschi M: Suggested connections between risk factors of intracranial aneurysms: a review. Ann Biomed Eng 2013;41:1366-1383.
17.
Muller HR, Brunholzl C, Radu EW, Buser M: Sex and side differences of cerebral arterial caliber. Neuroradiology 1991;33:212-216.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.